Update on the US Government's Biometric Consortium

Abstract

This talk is an update on the discussions of the Biometric Authentication Consortium held at previous CardTech/SecurTech conferences. The Consortium held its first meeting in October 1992 under the chairmanship of Dr. Benincasa. Since then, the Consortium has been meeting 2-3 times per year to provide a forum for information exchange on biometric-based personal identification/authentication technology among the Government, industry, and academia. In 1994, we broadened our scope by dropping Authentication from the name (to include identification) and Dr. Campbell and Ms. Alyea took over as chair and vice chair, respectively. The goals of the consortium remain largely the same under this new leadership. The current emphasis is on the formal approval of our charter and on the establishment of a national biometric test and evaluation laboratory. MISSION & FUNCTIONThe Biometric Consortium serves as a Government focal point for research, development, test, evaluation and application of biometric-based personal identification/authentication technology. The Consortium encourages the use and acceptance of biometric technology in areas of critical need, as well as concerning itself with maximizing performance, minimizing cost, and avoiding duplication of effort. The Consortium coordinates technological concerns and issues of performance and efficiency within the Government in order to serve the best interests of the taxpayer. To accomplish these objectives, the Consortium will:Promote the science and performance of biometrics Establish standardized testing databases, procedures and protocols Provide a forum for information exchange among the Government, industry, and academia Establish increased Government and commercial interaction Establish symposia/workshops to include the contributions of academia and private industry Establish a feedback mechanism for issues that are exposed during the actual application of this technology Address the safety, performance, legal and ethical issues surrounding this technology.Biometric Consortium 1 of 4 9/6/00 11:36 AM

Overview of recent developments in the flame retardancy of polycarbonates

“…Recently, GE patented a series of bisphosphoramidates with a piperazine bridging unit (eg ( XXXVIII )) 188–190. These products are effective in PC/ABS (V‐0 rating) at 12 wt% and as expected they provided high HDT.…”

Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life

“…Several nonpharmacological interventions have demonstrated empirical efficacy for headache management. As a result, they have become standard components of specialty headache centers and multidisciplinary pain management programs and are endorsed by the US Headache Consortium, 121 which consists of several professional agencies, including the American Headache Society, the American Academy of Neurology, and the National Headache Foundation. 122 Empirically validated effective nonpharmacological interventions may play an important role in both the acute and the preventive phases of the comprehensive headache management plan and may be offered individually or in conjunction with pharmacotherapy.…”

Developments in phosphorus flame retardants

“…28±30 Later, Clariant evidently found a lower cost route to the diethylphosphinate salts 31,32 and they commercialized the aluminum salt as Exolit Õ OP 930 (DEPAL), which also is useful in thermoset resins. 33,34 Although salts of dialkylphosphinic acid by themselves are only moderately efficient in nylons they were found to be synergistic with nitrogen-containing products such as melamine cyanurate, 35±37 melamine phosphate or melamine polyphosphate. 37 Based on this synergism, Clariant commercialized Exolit Õ OP 1311 for nylon 6 and Exolit Õ OP 1312 (also containing a stabilizer) for nylon 6.6.…”